| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Travere Therapeutics, Inc. (TVTX) have been net sellers, shedding 1,304,671 shares worth roughly $80.1M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. TVTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $11.64M | -243,735 | |
| VP | 117.1K | $2.62M | - | |
| Other | 105.4K | $6.88M | - | |
| VP | 100.5K | $6.56M | - | |
| Other | 98.2K | $1.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Dube Eric M56 | Chief Executive Officer | Sale+OE10b5-1 | 243,735 | $53.82 | $13,116,670.65 | -36.0% | - | - | |
| Sep 17, 2026 | Heerma Peter53 | EVP, Chief Commercial Officer | Sale+OE10b5-1 | 283,189 | $63.06 | $17,857,829.96 | -70.8% | - | - | |
| Sep 17, 2026 | Dube Eric M56 | Chief Executive Officer | Sale+OE10b5-1 | 400,000 | $63.48 | $25,390,729.21 | -48.0% | - | - | |
| Sep 16, 2026 | Rote William E.58 | Chief Research Officer | Sale+OE10b5-1 | 209,048 | $62.83 | $13,135,397.45 | -68.0% | - | - | |
| Sep 15, 2026 | Cline Christopher R.48 | Chief Financial Officer | Sale+OE10b5-1 | 50,508 | $62.34 | $3,148,543.99 | -36.6% | - | - | |
| Sep 15, 2026 | Inrig Jula | EVP, Head of R&D &CMO | Sale+OE10b5-1 | 44,674 | $62.34 | $2,785,020.69 | -30.8% | - | - | |
| Sep 15, 2026 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sale+OE10b5-1 | 5,375 | $62.33 | $335,004.60 | -11.3% | - | - | |
| Sep 15, 2026 | Reed Elizabeth E57 | Chief Legal Officer and GC | Sale+OE10b5-1 | 37,500 | $62.34 | $2,337,695.09 | -26.2% | - | - | |
| Sep 10, 2026 | Meckler Jeffrey A45 | Director | Sale+OE10b5-1 | 20,000 | $67.31 | $1,346,106.29 | -17.9% | - | - | |
| Sep 2, 2026 | Cline Christopher R.48 | Chief Financial Officer | Sell | 642 | $66.37 | $42,609.54 | -0.5% | - | - |